LINC01231

Across TCGA pan-cancer cohorts, LINC01231 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01231 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01231 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01231 expression acts as an unfavorable survival marker, although some lineages such as OV and MESO show a favorable association.

COAD, UVM, and ACC are the cancer types where LINC01231 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Tertile	All	0.392	0.722	<.001	81	view →
UVM	OS	Tertile	All	0.104	0.834	<.001	63	view →
ACC	OS	Tertile	All	0.145	0.705	.002	54	view →
OV	OS	Tertile	All	0.891	0.756	<.001	44	view →
THYM	OS	Tertile	III,IV	0.212	0.953	.009	36	view →
LGG	OS	Quartile	All	0.724	0.860	.001	34	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	30	view →
LUAD	DFS	Tertile	All	0.360	0.685	.005	30	view →
KIRC	DFS	Tertile	IV	0.234	0.619	<.001	18	view →
MESO	OS	Median	All	0.739	0.285	.002	15	view →
BLCA	OS	Tertile	III,IV	1.000	0.244	.047	6	view →
STAD	DFS	Tertile	All	0.553	0.680	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01231–COAD (DFS)

Open the COAD breakdown →